All News
Links:
Dr. John Cush RheumNow ( View Tweet)
Links:
Dr. John Cush RheumNow ( View Tweet)
PFAPA (aka Marshall syndrome) also occurs in adults @RWCSmtg https://t.co/52NVpKGCzP
Dr. Susan Shenoy @rwcs shows discovery of autoinflammatory diseases began w MEFV genes (FMF) in 1997, followed by genes for TRAPS and HIDS in 1999. @ https://t.co/sG4BlK1zhR
Links:
Links:
Links:
Dr. John Cush RheumNow ( View Tweet)
Links:
Dr. John Cush RheumNow ( View Tweet)
Links:
Dr. John Cush RheumNow ( View Tweet)
Medicine Matters rheumatology Rheum_Matters ( View Tweet)
Links:
Links:
Links:
Dr. John Cush RheumNow ( View Tweet)
COVID Vaccine Q & A - Dr Kevin Winthrop Dr. Cush interviews Dr. Kevin Winthrop (OHSU) on the use and caveats to COVID-19 vaccination in patients with rheumatic disease and taking biologic and DMARD therapies https://t.co/EJL6hVLnrp https://t.co/XOHk9T04rx
Links:
NEJM: Early Combo Monoclonal Antibody Therapy in COVID-19
NEJM has published the interim analysis of the REGN-COV2 trial, wherein an antibody cocktail reduced viral loads with less clinical consequences.
Read ArticleCombo Anti-Spike Protein Antibody for Mild to Moderate COVID-19
JAMA has published the BLAZE-1 study, showing significant SARS-CoV-2 viral load reduction at day 11 and less COVID-19 progression when combination anti-spike monoclonal antibody therapy (bamlanivimab and etesevimab) was given to mild to moderate, non-hospitalized COVID-19 patients.
Read Article